The Nitroxide 4-methoxy-tempo Inhibits the Pathogenesis of Dextran Sodium Sulfate-stimulated Experimental Colitis
Overview
Cell Biology
Endocrinology
Authors
Affiliations
Inflammatory bowel disease (IBD) is a chronic condition characterised by leukocyte recruitment to the gut mucosa. Leukocyte myeloperoxidase (MPO) produces the two-electron oxidant hypochlorous acid (HOCl), damaging tissue and playing a role in cellular recruitment, thereby exacerbating gut injury. We tested whether the MPO-inhibitor, 4-Methoxy-TEMPO (MetT), ameliorates experimental IBD. Colitis was induced in C57BL/6 mice by 3% w/v dextran-sodium-sulfate (DSS) in drinking water ad libitum over 9-days with MetT (15 mg/kg; via i. p. injection) or vehicle control (10% v/v DMSO+90% v/v phosphate buffered saline) administered twice daily during DSS challenge. MetT attenuated body-weight loss (50%, p < 0.05, n = 6), improved clinical score (53%, p < 0.05, n = 6) and inhibited serum lipid peroxidation. Histopathological damage decreased markedly in MetT-treated mice, as judged by maintenance of crypt integrity, goblet cell density and decreased cellular infiltrate. Colonic Ly6C, MPO-labelled cells and 3-chlorotyrosine (3-Cl-Tyr) decreased in MetT-treated mice, although biomarkers for nitrosative stress (3-nitro-tyrosine-tyrosine; 3-NO-Tyr) and low-molecular weight thiol damage (assessed as glutathione sulfonamide; GSA) were unchanged. Interestingly, MetT did not significantly impact colonic IL-10 and IL-6 levels, suggesting a non-immunomodulatory pathway. Overall, MetT ameliorated the severity of experimental IBD, likely via a mechanism involving the modulation of MPO-mediated damage.
San Gabriel P, ONeil T, Au A, Tan J, Pinget G, Liu Y Int J Mol Sci. 2024; 25(8).
PMID: 38673843 PMC: 11050303. DOI: 10.3390/ijms25084258.
The Cellular and Organismal Effects of Nitroxides and Nitroxide-Containing Nanoparticles.
Sadowska-Bartosz I, Bartosz G Int J Mol Sci. 2024; 25(3).
PMID: 38338725 PMC: 10855878. DOI: 10.3390/ijms25031446.
Preserving Retinal Structure and Function with the Novel Nitroxide Antioxidant, DCTEIO.
Rayner C, Bottle S, Martyn A, Barnett N Neurochem Res. 2023; 48(11):3402-3419.
PMID: 37450210 PMC: 10514139. DOI: 10.1007/s11064-023-03978-w.
Michl T, Tran D, Kuckling H, Zhalgasbaikyzy A, Ivanovska B, Gonzalez Garcia L RSC Adv. 2022; 10(13):7368-7376.
PMID: 35492196 PMC: 9049834. DOI: 10.1039/c9ra09875e.
Schroder A, Chami B, Liu Y, Doyle C, El Kazzi M, Ahlenstiel G Inflamm Bowel Dis. 2021; 28(4):586-598.
PMID: 34724042 PMC: 9036391. DOI: 10.1093/ibd/izab239.